Mukka Proteins Ipo Gmp » National Chronicle

Mukka Proteins Subscription Status: Mukka Proteins, a fisheries company, has received an overwhelming response from investors during its initial public offering (IPO).

According to Bombay Stock Exchange (BSE) data, Mukka Proteins IPO was oversubscribed 136.99 times on the last day of IPO buying on Monday.

Mukka Proteins Subscription Status

As of the third and final day of the IPO, retail investors have subscribed 58.52 times, the non-institutional investors (NII) portion has been oversubscribed 250.38 times and the qualified institutional buyers (QIB) portion has been booked 189.28 times.

Mukka Proteins Subscription Status: On the very first day of opening of subscription, the retail investors’ portion was fully subscribed in the first two hours itself.

The total subscription rate on the first day was 2.47 times.

The retail portion was oversubscribed 3.70 times, the NII portion was oversubscribed 1.55 times and the QIB portion was oversubscribed 1.01 times.

This momentum continued on the second day and the subscription rate reached 6.97 times.

Retail investors’ portion was subscribed 10.21 times, NII portion 6.22 times and QIB portion 1.86 times.

Mukka Proteins Subscription Status: Till the close of subscription on Monday, Mukka Proteins IPO has received bids for 7,67,16,38,920 shares against the total offer of 5,60,00,435 shares.

The value of the IPO is ₹224 crore. It consists of 8,00,00,000 equity shares face value with face value of Re 1 each.

Mukka Proteins plans to invest the proceeds from the IPO for general corporate purposes, its affiliates and Ento Proteins. Besides, other needs of the company will also be fulfilled.

Mukka Proteins Subscription Status: This issue opened on 29 February and closed on 4 March.

Mukka Proteins has reserved 50% shares for qualified institutional buyers, 15% for non-institutional investors and 35% for retail investors.

The Gray Market Premium (GMP) for Mukka Proteins IPO is currently +35, indicating a premium of ₹35 in the gray market.

This suggests that Mukka Proteins shares are trading at a premium and the estimated listing price is ₹63 per share, which is 125% higher than the IPO price of ₹28.

GPT Healthcare IPO Subscription Status: GPT Healthcare Limited on Thursday officially launched its Initial Public Offering (IPO) in the Indian market. This IPO will be available for purchase till Monday i.e. 26th February.

The company has fixed the price band of Rs 177 to Rs 186 for its equity shares. Also, GPT Healthcare is preparing for listing on both Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

GPT Healthcare IPO Subscription Status: Even before the IPO was launched in the market, GPT Healthcare has raised funding of Rs 157.54 crore from anchor investors.

Here, as of 10:18 am on the first day of bidding, the book build issue was subscribed 0.03 times, the retail portion was subscribed 0.05 times and the NII was subscribed 0.02 times.

GPT Healthcare IPO Subscription Status and Key Details

GMP (Grey Market Premium): According to market experts, shares of GPT Healthcare are trading in the gray market without any significant premium or discount.

Price Band: The multi-specialty hospital has set the issue price band at Rs 177 to Rs 186 per equity share.

How to cancel Paytm Fastag: Know each and everything

IPO Date: The IPO, which started today i.e. February 22, will remain open for subscription till February 26, 2024.

IPO size: GPT Healthcare aims to raise Rs 525.14 crore through its IPO, of which Rs 40 crore is expected to come from issuance of new shares and Rs 485.14 crore has been kept reserved for offer for sale (OFS).

Lot Size: The lot size for this IPO will be 80 shares.

Allotment Date: For now the allotment date is fixed for Tuesday, 27th February.

Registrar: Link Intime India Private Limited.

Listing: Proposed for listing on both BSE and NSE.

Listing Date: Following the T+3 listing rule, the IPO is expected to hit the secondary market on February 29, 2024.

GPT Healthcare IPO Subscription Status: Buy or Not

GPT Healthcare IPO Subscription Status: If believe on experts, this is a favorable opportunity to invest in a leading healthcare provider in eastern India. The company’s strategic focus, established presence and diverse healthcare services position it as a one-stop destination for patients’ needs. Operating in densely populated cities, GPT Healthcare exhibits healthy growth potential, catering to diverse economic sectors and increasing market penetration.

GPT Healthcare IPO Subscription Status: Investors are requested that the above article is given for information only. Use your discretion before applying for an IPO.

National Chronicle

Tag Archives: mukka proteins ipo gmp

News That Worth